Biotech Essentials

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 15.04.2021.

Biotechnology
Microbiology
Vaccination
Finance
Drug addiction
Thrombocytopenia

Career And Jobs

@Biotechnology shared
On Apr 13, 2021
2021 COVID-19 News: Breakthrough Cases, Children's Viral Load and More https://t.co/pcwSKRHPv8 https://t.co/4iFePfTY7M
Open
2021 COVID-19 News: Breakthrough Cases, Children's Viral Load and More

2021 COVID-19 News: Breakthrough Cases, Children's Viral Load and More

Please check out the biopharma industry's COVID-19 stories that are trending for April 13, 2021.

@biospace shared
On Apr 14, 2021
COVID-19 Brief: Theories on the COVID-19 blood clotting and more top stories #COVID-19 #clinicaltrials #vaccine https://t.co/500W7JTCfk
Open
COVID-19 Brief: Theories on the COVID-19 Blood Clotting and More Top Stories

COVID-19 Brief: Theories on the COVID-19 Blood Clotting and More Top Stories

The top COVID-19 story is on the pause of the Johnson & Johnson vaccine in the U.S. over rare blood clots. But it’s not the only news. Here’s a look.

@SynBioBeta shared
On Apr 14, 2021
Congratulations to @benchling for raising $200M! The company developed a cloud-based informatics platform to design DNA, collaborate on experiments, automate data capture, and manage research workflows with the aim of bringing products to market faster. https://t.co/Bc7JMDw6jP
Open
Benchling Raises $200M Series E To Accelerate Biotech R&D

Benchling Raises $200M Series E To Accelerate Biotech R&D

Led by Sequoia, new funding will fuel life sciences cloud leader’s global growth and product expansion SAN FRANCISCO, April 14, 2021 /PRNewswire/ — Benchling, the leading life sciences R&D ...

@MassBio shared
On Apr 9, 2021
RT @ldtimmerman: Timmerman Traverse sponsors: Faber Law. @5amVentures @ThirdRockV @baincapital @CBRE @DicernaPharma King St. Properties @MassBio RA Capital @QimingVC Browne Consulting @FoleyHoag Lightstone Ventures SR One @CRiverLabs @1ABMedia. More to come! @LS_Cares https://t.co/bXTiMpIrsp
Open
Timmerman Traverse for LSC: A Biotech Community Drive to Fight Poverty

Timmerman Traverse for LSC: A Biotech Community Drive to Fight Poverty

Like many people, I’m itching to get outside. Today, I’m excited to announce a new outdoor experience for a good cause: The Timmerman Traverse for Life Science Cares. It’s a Presidential ...

@JohnCendpts shared
On Apr 9, 2021
Lord $HOWL's moving castle: MPM-backed Werewolf, Merck-partnered Artiva make quick IPO flip while Luca Santarelli's biotech raises $127.5M By @AmberTongPW https://t.co/4rEznNNrGd
Open
MPM-backed Werewolf, Merck-partnered Artiva make quick IPO flip while Luca Santarelli's biotech raises $127.5M

MPM-backed Werewolf, Merck-partnered Artiva make quick IPO flip while Luca Santarelli's biotech raises $127.5M

The jump from crossover rounds to biotech IPO is quicker than ever. Just weeks after unveiling Series B rounds, MPM-backed Werewolf and Merck-partnered Artiva are spelling out plans to go ...

@JohnCendpts shared
On Apr 14, 2021
SPAC attack: It takes two to Tango: The biotech using CRISPR to discover new cancer gene targets rides a $353M SPAC deal to Nasdaq By @MaxGelman https://t.co/sOVck6chyr
Open
It takes two to Tango: The biotech using CRISPR to discover new cancer gene targets rides a $353M SPAC deal to Nasdaq

It takes two to Tango: The biotech using CRISPR to discover new cancer gene targets rides a $353M SPAC deal to Nasdaq

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here. The latest biotech-SPAC deal has arrived, and it's dancing its way to Nasdaq ...

@JohnCendpts shared
On Apr 13, 2021
Jaguar, Sean Nolan's latest biotech, raises $139M as they follow Taysha's footsteps https://t.co/OzDEXWXCUl
Open
Jaguar, Sean Nolan's latest biotech, raises $139M as they follow Taysha's footsteps

Jaguar, Sean Nolan's latest biotech, raises $139M as they follow Taysha's footsteps

Joe Nolan swears he isn't trying to hurtle Jaguar Gene Therapy toward a 0-to-60 IPO, but it sure looks like it. Less than two months after launching with Deerfield cash and ex-AveXis ...

@JohnCendpts shared
On Apr 13, 2021
Toad venom to treat depression? RA Capital wagers $125M on latest psychedelic biotech By @MaxGelman https://t.co/Ukqyg9gKMP
Open
Toad venom to treat depression? RA Capital wagers $125M on latest psychedelic biotech

Toad venom to treat depression? RA Capital wagers $125M on latest psychedelic biotech

Can an inhaled version of the psychedelic known as ‘toad venom’ be used to treat tough-to-crack depression? For GH Research, that’s the $125 million question. The Dublin-based biotech ...

Read more: Career And Jobs
weekly 15.04.2021
View archives
Back to home

Subscribe to Biotech Essentials - Career and Jobs.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Career and Jobs.
Privacy Policy

Sign up for the weekly Biotech Essentials - Career and Jobs newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Career and Jobs weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy